Clicky

Caribou Biosciences, Inc.(CRBU) News

Date Title
Jul 31 Biogen Inc. (BIIB) Surpasses Q2 Earnings and Revenue Estimates
Jul 21 July 2025's Promising Penny Stocks To Monitor
May 8 Caribou Biosciences Reports First Quarter 2025 Financial Results and Provides Business Update
May 6 Caribou Biosciences to Participate in the BofA Securities 2025 Health Care Conference
Apr 10 908 Devices Leads These 3 Penny Stocks To Consider
Jan 2 Caribou Biosciences Appoints Sri Ryali as Chief Financial Officer
Dec 30 Why Is Caribou Biosciences Inc. (CRBU) Among the Top CRISPR Stocks to Invest In?
Jun 3 Top Midday Decliners
Jun 2 Caribou Biosciences Presents Encouraging Clinical Data from CB-010 ANTLER Phase 1 Trial in Second-line LBCL Patients at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
May 30 Caribou Biosciences to Host KOL Discussion with Webcast from the 2024 ASCO Annual Meeting and Participate in Upcoming Investor Conferences
May 9 Caribou Biosciences, Inc. (NASDAQ:CRBU) Analysts Are Cutting Their Estimates: Here's What You Need To Know
May 7 Caribou Biosciences, Inc. (CRBU) Reports Q1 Loss, Misses Revenue Estimates
May 7 Caribou Biosciences Reports First Quarter 2024 Financial Results and Provides Business Update
May 1 Caribou Biosciences to Participate in Upcoming Investor Conferences
Apr 24 Caribou Biosciences to Present Initial Dose Expansion Data from CB-010 ANTLER Phase 1 Trial in r/r B-NHL at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Apr 15 Caribou Biosciences Announces Oral Presentation on In Vivo Cas12a chRDNA Genome Editing at the 27th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)
Apr 4 Caribou Biosciences Expands Clinical Development of CB-010 with FDA Clearance of IND in Lupus
Apr 1 With 65% institutional ownership, Caribou Biosciences, Inc. (NASDAQ:CRBU) is a favorite amongst the big guns
Mar 14 All You Need to Know About Caribou Biosciences, Inc. (CRBU) Rating Upgrade to Buy
Mar 13 11 Oversold NASDAQ Stocks To Buy Right Now